Assay validation for vilanterol and its metabolites in human urine with application for doping control analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Drug testing and analysis"
DOI: 10.1002/dta.3433
Abstract: A bioanalytical method for detecting the ultra-long-acting beta2 -agonist (U-LABA), inhaled vilanterol and its metabolites, GSK932009 and GW630200, in urine was developed to potentially monitor permitted therapeutic versus prohibited supratherapeutic use in sport. The World… read more here.
Keywords: vilanterol; gsk932009 gw630200; repeat dosing; vilanterol metabolites ... See more keywords